Overview
Follicular hamartoma-alopecia-cystic fibrosis syndrome is an extremely rare condition that has been described in medical literature but is now considered an obsolete diagnostic term (Orphanet code 2112). This means that the medical community no longer recognizes it as a distinct syndrome, and affected individuals may now be classified under other related conditions. The syndrome was originally described as a combination of follicular hamartomas (non-cancerous growths involving hair follicles in the skin), alopecia (hair loss), and features overlapping with cystic fibrosis (a condition that causes thick, sticky mucus to build up in the lungs and digestive system). Because this diagnosis is obsolete, patients who were previously given this label may benefit from being re-evaluated by a clinical geneticist using modern genetic testing. The original reports suggested skin abnormalities such as small bumps or growths on the skin related to hair follicles, patchy or widespread hair loss, and respiratory or digestive problems similar to those seen in cystic fibrosis. Treatment would have been directed at managing each individual symptom — for example, lung therapies for breathing problems, nutritional support for digestive issues, and dermatological care for skin findings. Because so few cases have been reported and the condition is no longer considered a separate entity, there is very limited information about its natural history, genetic cause, or long-term outlook. Patients and families are encouraged to seek updated genetic evaluation to determine whether a more current diagnosis applies.
Key symptoms:
Small non-cancerous skin growths around hair folliclesHair loss (partial or widespread)Thick mucus in the lungsFrequent lung infectionsDifficulty breathingPoor weight gain or growthDigestive problemsSkin bumps or unusual skin textureChronic cough
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Follicular hamartoma-alopecia-cystic fibrosis syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Follicular hamartoma-alopecia-cystic fibrosis syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Follicular hamartoma-alopecia-cystic fibrosis syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Follicular hamartoma-alopecia-cystic fibrosis syndrome.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Follicular hamartoma-alopecia-cystic fibrosis syndrome.
Start the conversation →Latest news about OBSOLETE: Follicular hamartoma-alopecia-cystic fibrosis syndrome
No recent news articles for OBSOLETE: Follicular hamartoma-alopecia-cystic fibrosis syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Is this diagnosis still considered valid, or should we pursue updated genetic testing?,Could my symptoms be explained by cystic fibrosis or another currently recognized condition?,What genetic tests would you recommend to clarify the diagnosis?,Are there any clinical trials or research studies that might be relevant?,What specialists should be part of my care team?,How should we manage the skin and hair symptoms?,What should I watch for that would require emergency medical attention?
Common questions about OBSOLETE: Follicular hamartoma-alopecia-cystic fibrosis syndrome
What is OBSOLETE: Follicular hamartoma-alopecia-cystic fibrosis syndrome?
Follicular hamartoma-alopecia-cystic fibrosis syndrome is an extremely rare condition that has been described in medical literature but is now considered an obsolete diagnostic term (Orphanet code 2112). This means that the medical community no longer recognizes it as a distinct syndrome, and affected individuals may now be classified under other related conditions. The syndrome was originally described as a combination of follicular hamartomas (non-cancerous growths involving hair follicles in the skin), alopecia (hair loss), and features overlapping with cystic fibrosis (a condition that cau
At what age does OBSOLETE: Follicular hamartoma-alopecia-cystic fibrosis syndrome typically begin?
Typical onset of OBSOLETE: Follicular hamartoma-alopecia-cystic fibrosis syndrome is childhood. Age of onset can vary across affected individuals.